Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Is in good health
Is confirmed human immunodeficiency virus (HIV)-uninfected
Is at low risk of HIV infection
For males, uses contraception in accordance with local regulations regarding contraception use for those participating in clinical trials
For females, is not pregnant or breastfeeding and one of the following applies:
Is not a participant of childbearing potential (POCBP)
Is a POCBP and uses an acceptable contraception method or is abstinent
You may not be if
Has an active diagnosis of hepatitis (B or C) due to any cause
Has a history of malignancy ≤5 years before signing informed consent
Has a history or current evidence of any condition that might confound study results or interfere with study participation
Has a history of keloid in upper arm or presence of tattoo, scar, or other physical finding that could interfere with implant placement (the contralateral arm may be used if the findings are limited to 1 arm)
Is taking or is expected to take immunosuppressants during the study
Clareo Health | Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)
